SELADELPAR AND REDUCTIONS IN LIPIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH AND WITHOUT STATIN USE IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE STUDY

Bowlus C., YILMAZ Y., Zigmond E., Hartleb M., Janczewska E., Andreone P., ...More

The Liver Meeting, California, United States Of America, 15 - 19 November 2024, vol.80, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 80
• City: California
• Country: United States Of America
• Recep Tayyip Erdoğan University Affiliated: Yes